Latest Strategic Growth Initiatives News

OncoSil Medical has reported a record 20% quarterly increase in dose sales and secured $8.7 million in new capital, underpinning its clinical and commercial expansion in pancreatic cancer treatment.

Mount Burgess Mining NL has secured agreements to extinguish nearly $4.7 million in legacy debt, converting a small portion into equity and options, positioning the company for renewed growth.

Australian Strategic Materials (ASM) reports significant progress in Q2 2025, including its first commercial heavy rare earth metals sale and a transformative low-cost production pathway at its Dubbo Project.

Credit Clear Limited has outperformed its FY25 financial guidance with a 76% rise in underlying EBITDA and secured exclusive digital debt recovery contracts with leading insurers, setting a robust stage for FY26 growth.

NEXION Group Ltd has issued 700,000 convertible notes to raise $70,000, supporting costs for a proposed acquisition. The notes carry a 10% interest rate and may convert to shares pending shareholder approval.

ARC Funds Limited has completed a $750,000 equity raise through a placement and director share subscription, supporting its recent acquisitions and growth strategy.

DY6 Metals has addressed an ASX price query by confirming confidential negotiations for acquiring additional mining licenses in Cameroon, explaining recent share price movements and ensuring compliance with continuous disclosure rules.

SunRice Group reported a 4% rise in net profit for FY25 alongside an 8% dividend increase, navigating inflation and currency volatility with strategic growth initiatives.

Fortifai Limited has successfully raised $2.3 million through an upsized share placement, aiming to bolster its AI Gaming Lab and technology partnerships. The capital injection will support ongoing operations and strategic growth initiatives.

Locate Technologies has raised an additional A$239,180 through its At-the-Market facility and expanded its Bitcoin treasury to over 10 BTC, reinforcing its financial strategy amid growth plans.

BetMakers Technology Group has successfully raised $11.5 million through a share placement aimed at repaying debt and funding strategic growth initiatives, including a potential acquisition in Nevada.

Telix Pharmaceuticals showcased its global theranostic radiopharmaceutical portfolio, highlighting FDA approvals, clinical progress, and a robust commercial expansion plan at its 2025 Investor Day.